Form 483

Allure Labs, LLC Form 483, 2015-08-21

FDA issued a Form 483 to Allure Labs, LLC on 2015-08-21 with 14 public-safe observations.

483· Form 483 issuedHuman Drugs14 observations

Allure Labs, LLC · Hayward, United States · Issued August 21, 2015

Overview

  • 14 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Aug 2015
21 CFR 211.142

Written warehousing procedures established/followed

Cited by Stephanie A Slater, Maida Henesian

21 Aug 2015
21 CFR 211.142

Written warehousing procedures established/followed

Cited by Stephanie A Slater, Maida Henesian

21 Aug 2015
21 CFR 211.180(e)(2)

Items to cover on annual reviews

Cited by Stephanie A Slater, Maida Henesian

21 Aug 2015
21 CFR 211.180(e)(2)

Items to cover on annual reviews

Cited by Stephanie A Slater, Maida Henesian

21 Aug 2015
21 CFR 211.188(b)(8)

Labeling control records including specimens or copies

Cited by Stephanie A Slater, Maida Henesian

Inspected site

ALAllure Labs, LLCHayward, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.142Cited across public-safe Form 483 observations2x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.188(b)(8)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.58Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)Cited across public-safe Form 483 observations2x
21 CFR 211.80(a)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 14 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere